Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...
FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...
On this week's I-80 Football Show, Dirk Chatelain joined Josh Peterson and Jack Mitchell for a look at the Nebraska football ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback